The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008–2013
Open accessAbstract
IMPORTANCE: Based on randomized evidence, expert guidelines in 2011 endorsed shorter, hypofractionated whole breast irradiation (WBI) for selected patients with early-stage breast cancer and permitted hypofractionated WBI for other patients. OBJECTIVES: To examine the uptake and costs of hypofractionated WBI among commercially insured patients in the United States. DESIGN, SETTING, AND PARTICIPANTS: Retrospective, observational cohort study, using administrative claims data from 14 commercial health care plans covering 7.4% of US adult women in 2013, we classified patients with incident early-stage breast cancer treated with lumpectomy and WBI from 2008 and 2013 into 2 cohorts: (1) the hypofractionation-endorsed cohort (n = 8924) included patients aged 50 years or older without prior chemotherapy or axillary lymph node involvement and (2) the hypofractionation-permitted cohort (n = 6719) included patients younger than 50 years or those with prior chemotherapy or axillary lymph node involvement. EXPOSURES: Hypofractionated WBI (3-5 weeks of treatment) vs conventional WBI (5-7 weeks of treatment). MAIN OUTCOMES AND MEASURES: Use of hypofractionated and conventional WBI, total and radiotherapy-related health care expenditures, and patient out-of-pocket expenses. Patient and clinical characteristics included year of treatment, age, comorbid disease, prior chemotherapy, axillary lymph node involvement, intensity-modulated radiotherapy, practice setting, and other contextual variables. RESULTS: Hypofractionated WBI increased from 10.6% (95% CI, 8.8%-12.5%) in 2008 to 34.5% (95% CI, 32.2%-36.8%) in 2013 in the hypofractionation-endorsed cohort and from 8.1% (95% CI, 6.0%-10.2%) in 2008 to 21.2% (95% CI, 18.9%-23.6%) in 2013 in the hypofractionation-permitted cohort. Adjusted mean total health care expenditures in the 1 year after diagnosis were $28,747 for hypofractionated and $31,641 for conventional WBI in the hypofractionation-endorsed cohort (difference, $2894; 95% CI, $1610-$4234; P < .001) and $64,273 for hypofractionated and $72,860 for conventional WBI in the hypofractionation-permitted cohort (difference, $8587; 95% CI, $5316-$12,017; P < .001). Adjusted mean total 1-year patient out-of-pocket expenses were not significantly different between hypofractionated vs conventional WBI in either cohort. CONCLUSIONS AND RELEVANCE: Hypofractionated WBI after breast conserving surgery increased among women with early-stage breast cancer in 14 US commercial health care plans between 2008 and 2013. However, only 34.5% of patients with hypofractionation-endorsed and 21.2% with hypofractionation-permitted early-stage breast cancer received hypofractionated WBI in 2013.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Cited by
Smith, B. D., Bellon, J. R., Blitzblau, R., Freedman, G., Haffty, B., Hahn, C., Halberg, F., Hoffman, K., Horst, K., Moran, J., et al. (2018) · Practical Radiation Oncology · doi:10.1016/j.prro.2018.01.012 · Cited by 614
Self-citationClinical Diagnosis and Management of Breast Cancer
McDonald, E. S., Clark, A. S., Tchou, J., Zhang, P., & Freedman, G. M. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.157834 · Cited by 613
Self-citationRecent advances in functional nanomaterials for light–triggered cancer therapy
Gai, S., Yang, G., Yang, P., He, F., Lin, J., Jin, D., & Xing, B. (2018) · Nano Today · doi:10.1016/j.nantod.2018.02.010 · Cited by 568
Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic
Chen, R. C., Haynes, K., Du, S., Barron, J., & Katz, A. J. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.0884 · Cited by 315
Self-citationShaitelman, S. F., Schlembach, P. J., Arzu, I., Ballo, M., Bloom, E. S., Buchholz, D., Chronowski, G. M., Dvorak, T., Grade, E., Hoffman, K. E., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.2666 · Cited by 269
Metadata
- Authors
- Bekelman, J. E., Sylwestrzak, G., Barron, J., Liu, J., Epstein, A. J., Freedman, G., Malin, J., & Emanuel, E. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2014-12-17
- Volume
- 312
- Issue
- 23
- Pages
- 2542
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W1990637325
- Cited by
- 215
- References
- 1
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008–2013. https://app.cochat.ai/papers/10.1001/jama.2014.16616
- The paper
- Bekelman, J. E., Sylwestrzak, G., Barron, J., Liu, J., Epstein, A. J., Freedman, G., Malin, J., & Emanuel, E. J. (2014). Uptake and Costs of Hypofractionated vs Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008–2013. JAMA. https://doi.org/10.1001/jama.2014.16616
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.